RxDoctor Payments Data

Sara Ocker

Psychiatric/Mental Health · Cambridge, MNNPI 1427624584

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,803 of the $2,618 with a category attached, or 68.9%. Neuronetics, Inc. accounts for 84.2% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2023 at $1,714 and has fallen 95.7% since, to $74 in 2025. Among psychiatric/mental health clinicians in MN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,618in general payments, 2019–2025

Across 35 payments — averaging $74.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Neuronetics, Inc.$2K
  • Supernus Pharmaceuticals, Inc.$77
  • Tempus AI, Inc$55
  • Indivior Inc.$46
  • Neurocrine Biosciences, Inc.$43
  • Lundbeck LLC$40
  • plus $152 from 7 others

What the payments were for

  • Travel & lodging$81531%
  • Food & beverage$1,80369%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,618 in reported general payments places this provider in the 95th percentile of 407 psychiatric/mental health providers in Minnesota.

See all psychiatric/mental health providers in Minnesota

Medicare billing

Part B allowed, 2024
$10,342
Medicare patients
19
Services billed
115

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
CaplytaLumateperone Tosylate15$24,316
Aripiprazole27$4,449
Quetiapine Fumarate ErQuetiapine Fumarate11$1,196
Haloperidol24$1,019
Duloxetine Hcl62$894
Hydroxyzine Hcl38$846
Prazosin Hcl25$748
Quetiapine Fumarate57$721
Trazodone Hcl59$698
Buspirone Hcl52$610
Desvenlafaxine Succinate ErDesvenlafaxine Succinate13$591
Lamotrigine56$474
Venlafaxine Hcl ErVenlafaxine Hcl33$393
Fluoxetine Hcl38$379
Methylphenidate Hcl13$376

Paid to pharmacies, not to this prescriber.

Other psychiatric/mental health in Cambridge

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →